Woburn, MA (PRWEB) November 26, 2013
PathoGenetix, Inc., developer of an automated system for rapid bacterial identification, announced today that it has completed the first round of customer evaluations for its RESOLUTION™ Microbial Genotyping System. The RESOLUTION Customer Experience Program gives key prospects in critical target markets a hands-on, in-depth review of the company’s rapid bacterial identification system, and is an important step in the commercialization of the System, which will be available in 2014 for use in food safety testing and foodborne illness outbreak investigations.
The RESOLUTION Customer Experience Program enables potential customers to visit PathoGenetix and participate in a two-day workshop that provides a detailed review of the RESOLUTION Microbial Genotyping System including hands-on time with the instrument, bioinformatics software and database, and pathogen-specific assays for Salmonella and E. coli. Customer feedback on user requirements, utility and ease-of-use of the System is also a key component of the Program.
PathoGenetix’s first round of onsite evaluations focused on leading contract testing labs serving the food safety market. Many food producers worldwide rely on third party contract laboratories for all or part of their food quality and safety testing programs.
Wisconsin-based Marshfield Food Safety, LLC, was one of five contract testing laboratories to visit PathoGenetix in October and November for the RESOLUTION Customer Experience Program. Marshfield provides full service microbiology and chemistry testing and food safety risk management services to clients along the food chain from farm to table.
Marshfield CEO, Roy Radcliff, PhD, said of the potential impact of the RESOLUTION System on food safety testing, “The RESOLUTION System could change how pathogen confirmations are performed in testing laboratories. The ability to identify and differentiate multiple serotypes from a single sample could give our customers the ability to quickly identify sources of contamination and track specific organisms through a production facility.”
“The RESOLUTION Customer Experience Program provides important input for PathoGenetix as we develop our innovative technology into a powerful new food safety solution for the food industry and public health agencies,” said John Czajka, PhD, PathoGenetix’s Vice President of Business Development. “By offering industry experts the opportunity to work with the RESOLUTION System, they have been able to see first-hand both the simplicity of the System and its exceptional pathogen characterization capabilities. PathoGenetix has been able to get detailed customer feedback that will enable us to fine tune the System to further match end-user requirements and existing laboratory workflows.”
PathoGenetix will be offering the RESOLUTION Customer Experience Program again in 2014, with a focus on food production companies that conduct food safety testing in-house.
About PathoGenetix, Inc.
PathoGenetix, Inc. is a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. PathoGenetix is a venture-backed company that has received more than $50 million in technology development funding from the Department of Homeland Security. The company’s core Genome Sequence Scanning™ (GSS™) technology isolates and analyzes DNA directly from an enriched biological sample—without the need for a cultured isolate—and provides results in just five hours, days faster than current methods. GSS has broad applicability in food safety, industrial microbiology, and clinical diagnostics and research. The first commercial GSS system will be available in 2014 for use in food safety testing and foodborne illness outbreak investigations. Learn more at http://www.pathogenetix.com.